Carson Wealth (CWM LLC)
NVCR icon

Carson Wealth (CWM LLC)’s NovoCure NVCR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$251K Buy
23,049
+2,277
+11% +$28.4K ﹤0.01% 2533
2025
Q4 		$269K Buy
20,772
+9,213
+80% +$118K ﹤0.01% 2325
2025
Q3 		$149K Buy
11,559
+8,893
+334% +$119K ﹤0.01% 2677
2025
Q2 		$47K Buy
2,666
+155
+6% +$2.7K ﹤0.01% 3331
2025
Q1 		$45K Buy
2,511
+40
+2% +$908 ﹤0.01% 3063
2024
Q4 		$74K Buy
2,471
+315
+15% +$6.67K ﹤0.01% 2492
2024
Q3 		$34K Sell
2,156
-3,125
-59% -$56.7K ﹤0.01% 2995
2024
Q2 		$90K Buy
5,281
+3,410
+182% +$60K ﹤0.01% 2035
2024
Q1 		$29K Buy
1,871
+116
+7% +$1.71K ﹤0.01% 2658
2023
Q4 		$26K Sell
1,755
-2,136
-55% -$28.6K ﹤0.01% 2601
2023
Q3 		$63K Buy
3,891
+2,184
+128% +$63K ﹤0.01% 1931
2023
Q2 		$71K Sell
1,707
-344
-17% -$21.4K ﹤0.01% 1765
2023
Q1 		$123K Sell
2,051
-28
-1% -$2.24K ﹤0.01% 1387
2022
Q4 		$152K Buy
2,079
+238
+13% +$17.9K ﹤0.01% 1204
2022
Q3 		$140K Buy
1,841
+92
+5% +$7.18K ﹤0.01% 1188
2022
Q2 		$122K Buy
1,749
+133
+8% +$10K ﹤0.01% 1234
2022
Q1 		$134K Buy
1,616
+381
+31% +$28.1K ﹤0.01% 1210
2021
Q4 		$93K Buy
+1,235
New +$124K ﹤0.01% 1323
2021
Q2 		$306K Hold
1,381
– – ﹤0.01% 779
2021
Q1 		$306K Hold
1,381
– – ﹤0.01% 779
2020
Q4 		$306K Hold
1,381
– – ﹤0.01% 779
2020
Q3 		$306K Hold
1,381
– – ﹤0.01% 779
2020
Q2 		$306K Hold
1,381
– – ﹤0.01% 779
2020
Q1 		$306K Hold
1,381
– – ﹤0.01% 779
2019
Q4 		$306K Hold
1,381
– – ﹤0.01% 779
2019
Q3 		$306K Hold
1,381
– – ﹤0.01% 779
2019
Q2 		$306K Hold
1,381
– – ﹤0.01% 779
2019
Q1 		$306K Sell
1,381
-3,819
-73% -$184K ﹤0.01% 779
2018
Q4 		$174K Hold
5,200
– – ﹤0.01% 626
2018
Q3 		$272K Hold
5,200
– – 0.01% 460
2018
Q2 		$163K Buy
+5,200
New +$145K 0.01% 454

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NVCR Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its NovoCure (NVCR) stake by 11% in Q1 2026, buying an estimated $28.4K and bringing the position to 23,049 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Carson Wealth (CWM LLC) first reported a position in NVCR in Q2 2018 and has held it in 31 quarters since. The position peaked at $306K in Q2 2021. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Carson Wealth (CWM LLC) held 23,049 shares of NovoCure worth $251K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 2,277 NovoCure shares in Q1 2026, an estimated $28.4K.
  • NovoCure made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2533 holding.
  • Carson Wealth (CWM LLC) first reported a position in NovoCure in Q2 2018 and has held it in 31 quarters since.
  • Carson Wealth (CWM LLC)'s NovoCure position peaked at $306K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.